The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer

PURPOSE: The Prostate Health Index (phi) is a new test combining total, free and [-2]proPSA into a single score. It was recently approved by the FDA and is now commercially available in the U.S., Europe and Australia. We investigate whether phi improves specificity for detecting clinically significa...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Urol
Hlavní autoři: Loeb, Stacy, Sanda, Martin G., Broyles, Dennis L., Shin, Sanghyuk S., Bangma, Chris H., Wei, John T., Partin, Alan W., Klee, George G., Slawin, Kevin M., Marks, Leonard S., van Schaik, Ron H. N., Chan, Daniel W., Sokoll, Lori J., Cruz, Amabelle B., Mizrahi, Isaac A., Catalona, William J.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4404198/
https://ncbi.nlm.nih.gov/pubmed/25463993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2014.10.121
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky